scholarly journals TCT-410 Evaluation of the Acute and Long Term Renal Artery Re-Innervation Attempt Response Following Radiofrequency Catheter-Based Renal Nerve Ablation in a Swine Model: A Immunohistochemical Characterization

2014 ◽  
Vol 64 (11) ◽  
pp. B121
Author(s):  
Serge D. Rousselle ◽  
Randy Hart ◽  
Javier A. Garza ◽  
Joan Wicks ◽  
Armando Tellez
Hypertension ◽  
2021 ◽  
Vol 78 (Suppl_1) ◽  
Author(s):  
Andrew Sharp ◽  
Stefan Tunev ◽  
Markus P Schlaich ◽  
David P LEE ◽  
Aloke Finn ◽  
...  

Background: The safety and efficacy of catheter-based radio frequency (RF) renal denervation (RDN) have been demonstrated in randomized, sham-controlled trials. Long-term durability of blood pressure reduction following RDN has also been demonstrated by all-comer registries, although published pre-clinical reports of functional renal nerve regrowth are not consistent. We quantified the processes that support RDN procedural durability utilizing animal models. Methods: Animal studies were conducted in accordance with published guidelines. RDN was performed (4 lesions in the main renal artery) in normotensive swine using the Symplicity Spyral™ RDN system (Medtronic, Santa Rosa, CA, USA). Two additional groups not undergoing RDN served as control. Serial histological tissue samples were obtained in separate groups at 7 (n=12/group) and 180 (N=16/group) days post-procedure in all animals followed by bioanalytical quantification of cortical norepinephrine (NE) levels and immunohistochemical analysis of renal cortical axon density in matched samples. Results: Renal cortical axon density and NE levels were significantly reduced at 7 days and persisted through 180 days following RDN compared with control ( Figure ). Nerve fibrosis and necrosis were observed in the region of ablation, while nerve body atrophy was apparent distal to ablation location at 180 days. Conclusions: Reductions in both NE and renal cortical axon density were sustained at 7 and 180 days post-RDN procedure using RF renal denervation in a normotensive swine model. These data confirm and extend other pre-clinical and clinical evidence of long-term durability of the RDN procedure using RF energy.


2018 ◽  
pp. 891-901 ◽  
Author(s):  
M. TÁBORSKÝ ◽  
D. RICHTER ◽  
Z. TONAR ◽  
T. KUBÍKOVÁ ◽  
A. HERMAN ◽  
...  

This study evaluated the subacute morphologic alterations in renal artery wall and renal nerves in response to catheter-based renal denervation (RDN) in sheep and also compared the efficiency of single-point and multiple-point ablation catheters. Effect of each ablation catheter approved for the clinical use (Symplicity FlexTM, Medtronic, Inc., or EnligHTNTM, St. Jude Medical, INC.) was compared to intact contralateral renal artery in 12 sheep by histopathology and immunohistochemistry evaluation after a 10-day period post-RDN procedure. The safety was verified by extensive evaluation of kidney morphology. Vascular wall lesions and nerve injuries were more pronounced in those animals treated with multi-point EnligHTN catheter when compared with animals treated with single-point Symplicity Flex catheter. However, neither RDN procedure led to complete renal nerve ablation. Both systems, tested in the present study, provided only incomplete renal nerve ablation in sheep. Moreover, no appreciable progression of the nerve disintegration in subacute phase post-RDN procedure was observed. This study further supports the notion that the effectiveness remains fully dependent on anatomical inter-individual variability of the sympathetic nerve plexus accompanying the renal artery. Therefore, new systems providing deeper penetrance to targeted perivascular structure would be more efficient.


Hypertension ◽  
2013 ◽  
Vol 62 (suppl_1) ◽  
Author(s):  
Juan Gao ◽  
Frank W Smart ◽  
Daniel R Kapusta

Radiofrequency catheter ablation (RF-ABL) of the renal arteries decreases blood pressure in patients with drug-resistant hypertension. This study investigated whether RF-ABL of the renal arteries alters blood pressure (BP) in an animal model of essential hypertension, the spontaneously hypertensive rat (SHR). Methods Nineteen-week old male SHR were instrumented with radio-telemetry probes for chronic measurement of BP (Systolic, SBP; Diastolic, DBP). After 1-week, control BP was measured in rats for 3 days. The next day SHR were anesthetized and randomly received either bilateral Sham-ABL (n=5) or RF-ABL (n=6) of the renal arteries (Biosense Webster Stockert 70 generator and RF-probe). The tip of the RF-probe was applied externally to a small dissected segment of each renal artery and stimulated circumferentially (10 Watts). BP was then measured three times a week for 8 weeks. Results In anesthetized hypertensive SHR, RF-ABL of a single renal artery did not alter BP. In contrast, subsequent RF-ABL of the contralateral renal artery produced an immediate (<15 seconds) decrease in mean arterial blood pressure (MAP, range Δ -60 to -100 mmHg). BP in hypertensive SHR was not altered during or after the Sham-RF procedure. In conscious SHR, BP was significantly decreased the day after RF-ABL (153±8/102±4 mmHg) and throughout the post-ABL study (4-week SBP/DBP, 173±7/120±5; 8-weeks, 171±6/116±4 mmHg) compared to pre-ABL control levels (SBP/DBP, 187±9/130±5 mmHg). At the end of week-1 the peak increase in MAP to cage switch stress was significantly blunted and the time to return to basal BP was shortened in RF-ABL (peak Δ 18±5 mmHg; 30-min to basal) vs. Sham-ABL (peak Δ 32±3 mmHg; 70-min to basal). At the end of week-8, the hypotensive response to i.p. chlorisondamine was blunted in RF-ABL (Δ -39±4 mmHg) vs. Sham-ABL rats (Δ -53±2 mmHg). Conclusions These data demonstrate that in hypertensive SHR, bilateral RF-ABL of the renal arteries produces, presumably via blockade of renal sympathetic afferent/efferent neural pathways, a reduction in BP, which by 4-weeks is reset to a lower basal level. These findings indicate that RF-ABL can be used in rodents to investigate the therapeutic mechanisms by which endovascular renal denervation reduces blood pressure in hypertension.


2021 ◽  
Vol 10 (2) ◽  
pp. 326
Author(s):  
Grégory Secco ◽  
Olivier Chevallier ◽  
Nicolas Falvo ◽  
Kévin Guillen ◽  
Pierre-Olivier Comby ◽  
...  

The endovascular treatment of renal artery aneurysms (RAAs) has lower morbidity and shorter stay lengths compared to surgical repair. Here, we describe coil packing with or without remodeling and assess outcomes and complications. We retrospectively identified the 19 consecutive preventive endovascular RAA coil embolizations done in 18 patients at our center in 2010–2020. Patient and aneurysm characteristics, technical success rate, complications, and recurrences were recorded. Mean patient age was 63 ± 13 years. The RAA was >1.5 cm in 11 cases, and in four cases, the aneurysm-to-parent artery size ratio was >2. Simple coiling was performed for 11 (57.9%) aneurysms, stent-assisted coiling for seven (36.8%) aneurysms, and balloon-assisted coiling for one (5.3%) aneurysm. Technical success rate was 100%. Complete definitive RAA exclusion was achieved with a single procedure for 17 (89.5%) aneurysms, whereas two (10.5%) aneurysms required a repeat procedure. Four minor complications occurred but resolved with no long-term consequences. No major complications occurred during the mean follow-up of 41.1 ± 29.7 months. Coil embolization by sac packing or remodeling proved very safe and effective. Together with the known lower morbidity and shorter stay length compared to open surgery, these data indicate that this endovascular procedure should become the preventive treatment of choice for RAAs.


1998 ◽  
Vol 12 (3) ◽  
pp. 270-277 ◽  
Author(s):  
Mark J. Kulbaski ◽  
Andrzej S. Kosinski ◽  
Robert B. Smith ◽  
Atef A. Salam ◽  
Thomas F. Dodson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document